{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-21T04:47:00.160454+00:00","published_at":"2026-10-21T04:47:00.160454+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1ajhrmkcsd460","event_type":"CFO_CHANGED","effective_at":"2026-04-23","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:cory-ellspermann","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:38e353ee170527fb06612cfedc684cae6baa6465903d188efcb45e26837c3da3"],"summary":"Cory Ellspermann executive of Inmune Bio, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:78zn671d5s5w5","event_type":"CEO_CHANGED","effective_at":"2026-04-23","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:david-j-moss","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:6347c6e5b3b61ce18610386aa511593e480ddb8e6937a3682a1692e07ae29845"],"summary":"David J. Moss executive of Inmune Bio, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3yf50z46orzr","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-23","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:mark-lowdell-phd","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:f6b8c92cf510113f7856db68394c4b64387a2eaa510f601ed7c861c784724190"],"summary":"Mark Lowdell, PhD executive of Inmune Bio, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1b3l5lzcz8eet","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:david-j-moss","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"David J. Moss seat on Inmune Bio, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14qx7eg1r3wjfg","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:marcia-allen","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"Marcia Allen seat on Inmune Bio, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hhlhlik5egz4","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:committee:inmune-bio-inc:audit-nominating-and-governance-chair","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"Audit; Nominating and Governance · Chair committee of Inmune Bio, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ekqz71da9u1b","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:marcia-allen","alpha:committee:inmune-bio-inc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"Marcia Allen member of Audit; Nominating and Governance · Chair, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1pwzq9gsm2t3i","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:scott-juda-j-d","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"Scott Juda, J.D. seat on Inmune Bio, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bhj79418zl1ce","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:j-kelly-ganjei","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"J. Kelly Ganjei seat on Inmune Bio, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:bno62l6ot6h1","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:timothy-schroeder","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"Timothy Schroeder seat on Inmune Bio, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bs17qt1krn06d","event_type":"COMMITTEE_CREATED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:committee:inmune-bio-inc:audit-compensation-chair","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"Audit; Compensation · Chair committee of Inmune Bio, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1g47pjvrbth9","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:timothy-schroeder","alpha:committee:inmune-bio-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"Timothy Schroeder member of Audit; Compensation · Chair, effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1836i1qokq87m","event_type":"COMMITTEE_CREATED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:committee:inmune-bio-inc:compensation-nominating-and-governance","alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"Compensation; Nominating and Governance committee of Inmune Bio, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1x25f6qanc2dk","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:00.160454+00:00","subject_ids":["alpha:person:j-kelly-ganjei","alpha:committee:inmune-bio-inc:compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a"],"summary":"J. Kelly Ganjei member of Compensation; Nominating and Governance, effective 2016-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:5","subject_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-j-moss","object_label":"David J. Moss","object_source_name_forms":[],"value":"David J. Moss: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-j-moss","name":"David J. Moss"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:00.160454+00:00","sources":[{"id":"alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Inmune Bio, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:28:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:6","subject_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:j-kelly-ganjei","object_label":"J. Kelly Ganjei","object_source_name_forms":[],"value":"J. Kelly Ganjei: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:j-kelly-ganjei","name":"J. Kelly Ganjei"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:00.160454+00:00","sources":[{"id":"alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Inmune Bio, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:28:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:7","subject_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:marcia-allen","object_label":"Marcia Allen","object_source_name_forms":[],"value":"Marcia Allen: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:marcia-allen","name":"Marcia Allen"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:00.160454+00:00","sources":[{"id":"alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Inmune Bio, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:28:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:8","subject_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:scott-juda-j-d","object_label":"Scott Juda, J.D.","object_source_name_forms":[],"value":"Scott Juda, J.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:scott-juda-j-d","name":"Scott Juda, J.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:00.160454+00:00","sources":[{"id":"alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Inmune Bio, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:28:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:9","subject_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:timothy-schroeder","object_label":"Timothy Schroeder","object_source_name_forms":[],"value":"Timothy Schroeder: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:timothy-schroeder","name":"Timothy Schroeder"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:00.160454+00:00","sources":[{"id":"alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Inmune Bio, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:28:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:10","subject_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:cory-ellspermann","object_label":"Cory Ellspermann","object_source_name_forms":[],"value":"Cory Ellspermann: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:cory-ellspermann","name":"Cory Ellspermann"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-21T04:47:00.160454+00:00","sources":[{"id":"alpha:projection-evidence:document:38e353ee170527fb06612cfedc684cae6baa6465903d188efcb45e26837c3da3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INMB DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T04:00:02.559811+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:11","subject_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-j-moss","object_label":"David J. Moss","object_source_name_forms":[],"value":"David J. Moss: President, CEO, Secretary, Treasurer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-j-moss","name":"David J. Moss"},"title":"President, CEO, Secretary, Treasurer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-21T04:47:00.160454+00:00","sources":[{"id":"alpha:projection-evidence:document:6347c6e5b3b61ce18610386aa511593e480ddb8e6937a3682a1692e07ae29845","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INMB DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T04:00:01.618182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:12","subject_id":"alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-lowdell-phd","object_label":"Mark Lowdell, PhD","object_source_name_forms":[],"value":"Mark Lowdell, PhD: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mark-lowdell-phd","name":"Mark Lowdell, PhD"},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-21T04:47:00.160454+00:00","sources":[{"id":"alpha:projection-evidence:document:f6b8c92cf510113f7856db68394c4b64387a2eaa510f601ed7c861c784724190","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INMB DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T04:00:03.346351+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Inmune Bio, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:28:01.101+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:38e353ee170527fb06612cfedc684cae6baa6465903d188efcb45e26837c3da3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INMB DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T04:00:02.559811+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:6347c6e5b3b61ce18610386aa511593e480ddb8e6937a3682a1692e07ae29845","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INMB DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T04:00:01.618182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f6b8c92cf510113f7856db68394c4b64387a2eaa510f601ed7c861c784724190","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INMB DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T04:00:03.346351+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.835,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.876,"cross_source_agreement":0.75,"temporal_completeness":0.571},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-21T04:47:00.160454+00:00","observed_at":"2026-10-21T04:47:00.160454+00:00","reviewed_at":"2026-10-21T04:47:00.160454+00:00","verified_at":"2026-10-21T04:47:00.160454+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/inmune-bio-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}